DOD Glioblastoma, Transformative Consortium Award

The summary for the DOD Glioblastoma, Transformative Consortium Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept. of the Army -- USAMRAA, which is the U.S. government agency offering this grant.

DOD Glioblastoma, Transformative Consortium Award: The GBMRP recognizes the critical need for improved outcomes for individuals with glioblastoma. The GBMRP FY24 Transformative Consortium Award (TCA) is designed to support a multidisciplinary collaborative effort of at least four, but not more than five, distinct yet complementary projects that collectively address a central hypothesis. Applications for the TCA may propose clinical or translational research projects and/or clinical trials and must address at least one of the FY24 GBMRP Areas of Emphasis. This award requires a team-based approach by a consortium of exceptional researchers and at least one consumer advocate, whose collaborative efforts will catalyze scientific discovery, drive innovation, and make breakthroughs that could not be accomplished by a single investigator or group.